Trial of Ixazomib, Dexamethasone and Rituximab in Patients With Untreated Waldenstrom's Macroglobulinemia

This study is currently recruiting participants.
Verified April 2015 by Dana-Farber Cancer Institute
Sponsor:
Dana-Farber Cancer Institute
Collaborator:
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Jorge J. Castillo, MD, Dana-Farber Cancer Institute
 
https://clinicaltrials.gov/ct2/show/NCT02400437?term=ixazomib+castillo&rank=1